VaxCorps Overview

130+ investigative site locations across USA and Canada

Geographically diverse research centers with over 27,000 patients enrolled in over 25 vaccine trials, including COVID-19. Our sites have more depth and breadth of experience than any other vaccine network.

Access to more than 16M+ potential subjects nationwide

130+ investigative site locations across USA and Canada

Established patient database with access to a wide range of healthy patients as well as patients with a variety of conditions.

145 experience vaccine investigators

130+ investigative site locations across USA and Canada

145 experience vaccine investigators

APPI certified investigators (CPI) -

Pediatric, Adolescent, Adult, and Elderly average 11 years vaccine experience.

850 support staff

IBC registration and PBMC capabilities at various sites

145 experience vaccine investigators

More than half ACRP certified CCRCs.

Quality Assurance

IBC registration and PBMC capabilities at various sites

Ex-FDA investigator on staff to oversee compliance and quality initiatives.

IBC registration and PBMC capabilities at various sites

Study Efficiencies

Regulatory Document Submission within 48 hours of receipt
Study start-up goal is enrollment ready within two weeks of receiving initial regulatory packets
Investigator and staff training
Development of comprehensive recruitment plans for each site
Network support staff allowing sites to focus on studies
VaxCorps sites employ in-house call center focusing on patient recruitment, engagement, and retention for all studies and sites
Typical vaccine study has 175% of subjects pre-identified prior to First Patient First Visit (FPFV)
Early patient education
Investigator interaction with patients
Flexible office hours
Customer service oriented staff
Internal goals and benchmarks to ensure our targets are met
Patient stipend at each completed visit

Studies Completed

Anthrax/Anthrax vaccine absorbed

C.Difficile

Chikakungaya

Congenital Cytomegalovirus (CMV)

COVID-19

Ebola

E. Coli

Hepatitis B

Herpes

hMPV/PIV3

Influenza

Meningococcal (3)

Norovirus

Pertussis

Pneumococcal

RSV

Smallpox

Staph Aureus

Tdap

Varicella

Zika

Zoster

Our Alliance Partners

VaxCorps

VaxCorps Overview

130+ investigative site locations across USA and Canada

130+ investigative site locations across USA and Canada

130+ investigative site locations across USA and Canada

Access to more than 16M+ potential subjects nationwide

130+ investigative site locations across USA and Canada

130+ investigative site locations across USA and Canada

145 experience vaccine investigators

130+ investigative site locations across USA and Canada

145 experience vaccine investigators

850 support staff

IBC registration and PBMC capabilities at various sites

145 experience vaccine investigators

Quality Assurance

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

Who We Are

VaxCorps is a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adults, elderly, and pediatric populations

We have successfully conducted more than 500 Phase I - III vaccine clinical trials with the highest standards of research excellence

VaxCorps is committed to excellence - as industry leaders we effectively meet and exceed enrollment goals and adjust to tight timelines

Study Efficiencies

Studies Completed

VaxCorps Overview

130+ investigative site locations across USA and Canada

130+ investigative site locations across USA and Canada

130+ investigative site locations across USA and Canada

Access to more than 16M+ potential subjects nationwide

130+ investigative site locations across USA and Canada

130+ investigative site locations across USA and Canada

145 experience vaccine investigators

130+ investigative site locations across USA and Canada

145 experience vaccine investigators

850 support staff

IBC registration and PBMC capabilities at various sites

145 experience vaccine investigators

Quality Assurance

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

IBC registration and PBMC capabilities at various sites

Who We Are

VaxCorps is a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adults, elderly, and pediatric populations

We have successfully conducted more than 500 Phase I - III vaccine clinical trials with the highest standards of research excellence

VaxCorps is committed to excellence - as industry leaders we effectively meet and exceed enrollment goals and adjust to tight timelines

Study Efficiencies

Studies Completed

This website uses cookies.